Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1998 1
1999 1
2001 3
2002 1
2003 4
2004 1
2005 3
2006 1
2007 2
2008 3
2009 6
2010 6
2011 2
2012 6
2013 4
2014 3
2015 6
2016 6
2017 10
2018 11
2019 8
2020 12
2021 11
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 34475235

102 results
Results by year
Filters applied: . Clear all
Page 1
Hepatic artery injection of 131I-metuximab combined with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a prospective non-randomized, multicenter clinical trial.
Chen H, Nan G, Wei D, Zhai RY, Huang M, Yang WW, Xing BC, Zhu X, Xu HF, Wang XD, Zhang XY, Zhu BR, Liu P, Cao G, Gao S, Hao CY, Yang RJ, Guo JH, Zhang X, Gao K, Wang K, Wang JF, Li ZY, Zhu LZ, Ding R, Li J, Zhao L, Shao YJ, Liu HC, Xia JL, Wang L, Kong LM, Chen ZN, Bian H. Chen H, et al. J Nucl Med. 2021 Sep 2:jnumed.121.262136. doi: 10.2967/jnumed.121.262136. Online ahead of print. J Nucl Med. 2021. PMID: 34475235
Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety.
Wei W, Jian PE, Li SH, Guo ZX, Zhang YF, Ling YH, Lin XJ, Xu L, Shi M, Zheng L, Chen MS, Guo RP. Wei W, et al. Cancer Commun (Lond). 2018 Oct 10;38(1):61. doi: 10.1186/s40880-018-0331-y. Cancer Commun (Lond). 2018. PMID: 30305149 Free PMC article. Clinical Trial.
102 results